Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of intrauterine platelet-rich plasma injection in ICSI cycles with recurrent implantation failure
IRCT20160815029374N11Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2026
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous platelet-rich plasma in infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Clinical pregnancy event. Started Feb 2026; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20160815029374N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160815029374N11.